Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Exact Sciences Corporation burning huge operating expenses 750M loss last year on $1.8 Billion revenue. Insiders and exec have been selling from $130 all the way down to recent $40. I did a full research, you know how many shares they bought in the recent 8 months after a 70% drop? NONE ZERO. Cologuard at $680, has 92% accuracy with 13% false positive, 8% false negative, most doctors recommend colonoscopy because of cancer/polyp detections or a simple Fit-test for blood present at $25-$49. The chart technical and volume shows another 70% to fall to single digit to follow PACB pacific biosciences. Cathie wood (AARK) likes Exas with 4.4% ownership which is the kiss of death with new TV ads meaning more operating losses. make your own decisions. Thank you for the post. My 2 cents
SpyMasterTrades
â‹…
Great tip! I wonder, however, if it's going to retest the bottom before moving higher. Chart is looking like there's a fair possibility.
Thank you for the post. My 2 cents